Lans Holdings Inc (fka LAHO)

[ApollyonZ]

$LAHO..Stem..Market to Reach US$ 467 billion by 2024 ..Due to the increased funding from Government and Private sector and rising global awareness.

https://www.marketwatch.com/press-release/global-stem-cells-market-is-determined-to-reach-us-467-billion-by-2024-2019-03-05

..upsurge in venture capital investment represents growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html

Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/

.“There has been an increased demand to develop effective drugs for cardiology and degenerative disorders, for which there were no effective treatment plans before the advent of stem therapies. The discovery of possible cardiac stem cells uncovered new arenas to repair hearts injured due to acute myocardial infarction or coronary artery disease,”

https://www.dailyprogress.com/opinion/opinion-commentary-global-stem-cell-therapy-market-to-showcase-growth/article_aeabbd8e-0106-11e7-a193-db25ffa753ac.amp.html

GSCG is partnered with Magellan ($69 per share). So much potential for folks outside of healthcare, Shiller P/E 30x..

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149940407


..Stem Cell Banking Market to Witness Astonishing Growth

https://www.aglobalmarketresearch.com/stem-cell-banking-market-to-witness-astonishing-growth-of-10-cagr-by-2026-with-key-players-cord-blood-registry-cbr-systems-cordlife-group-limited-cryo-cell-international-viacord-cryo-save/

“Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health. “In many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive

Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30
https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/

$10M in debt (unlikely that high inherited) is insignificant vs 467B market likely grow to $trillion's per Oxford, Harvard, Mayo Clinic, NIH